Kisunla ( Donanemab ): Treatment for Early Symptomatic Alzheimer's Disease (AD)- Evidence Review on Amyloid Targeting Therapy
Date:
2026-01-29
Time:
5:30pm to 6:30pm
Organising Institute:
St. Teresa's Hospital & St. Paul's Hospital
Speaker:
Dr Olivia Tsz-Wa NG, Ph.D. in Neuroscience, Senior Manager in Medical Affairs, Eli Lilly Asia
Related CPE Activities: